Similares a Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD

20 vecinos (text_768) · 172 views · HCPLive · Estados Unidos


★	Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD	HCPLive @hcplivenews	172	Estados Unidos
9	Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata	HCPLive @hcplivenews	611	Estados Unidos	87
12	Is Long-Term JAK Inhibitor Use Safe for #Alopecia Areata?	HCPLive @hcplivenews	456	Estados Unidos	86
1	First Oral Therapy for #HidradenitisSuppurativa in Phase 3	HCPLive @hcplivenews	344	Estados Unidos	94
17	How New Biologics Are Changing #AtopicDermatitis Treatment	HCPLive @hcplivenews	274	Estados Unidos	86
16	How New Biologics Are Changing #AtopicDermatitis Treatment	HCPLive @hcplivenews	272	Estados Unidos	86
2	Results from the First Oral Phase 3 Therapy for #HidradenitisSuppurativa	HCPLive @hcplivenews	210	Estados Unidos	93
19	Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing	HCPLive @hcplivenews	209	Estados Unidos	86
13	How Much Hair Regrowth Did Upadacitinib Achieve in Severe Alopecia Areata?	HCPLive @hcplivenews	196	Estados Unidos	86
11	Vitiligo Pipeline Update: George Martin, MD, on JAK Inhibitors & Melasma Treatment	HCPLive @hcplivenews	143	Estados Unidos	87
10	How Are New Biologics Changing Atopic Dermatitis Treatment?	HCPLive @hcplivenews	137	Estados Unidos	87
8	How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD	HCPLive @hcplivenews	93	Estados Unidos	87
18	What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis?	HCPLive @hcplivenews	91	Estados Unidos	86
15	What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata	HCPLive @hcplivenews	82	Estados Unidos	86
5	Bimekizumab Data Support Case for Earlier Intervention in HS	HCPLive @hcplivenews	78	Estados Unidos	88
3	STOP-HS: Povorcitinib Shows Durable Response in HS at Week 54	HCPLive @hcplivenews	60	Estados Unidos	93
14	Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA	HCPLive @hcplivenews	30	Estados Unidos	86
6	Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD	HCPLive @hcplivenews	20	Estados Unidos	88
20	HCPLive Five: Maui Derm NP+PA Summer 2026	HCPLive @hcplivenews	20	Estados Unidos	85
4	BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS	HCPLive @hcplivenews	14	Estados Unidos	89
7	Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence \| Maui Derm	HCPLive @hcplivenews	11	Estados Unidos	87